Sensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
Amgen, Inc. is voluntarily recalling 9,565 bottles of Sensipar (cinacalcet) 30mg tablets nationwide due to CGMP manufacturing deviations. The recalled lot was distributed to patients taking the medication for secondary hyperparathyroidism.
- Product
- SENSIPAR — SENSIPAR (CINACALCET HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide